Disclosing the Novel Protective Mechanisms of Ocrelizumab in Multiple Sclerosis: The Role of PKC Beta and Its Down-Stream Targets

Lucrezia Irene Maria Campagnoli(University of Pavia), Alessia Pascale(University of Pavia)
International Journal of Molecular Sciences
August 16, 2024
Cited by 1


Related Papers